title: Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis.
abstract: Ras-association domain family 1A (RASSF1A), a candidate tumor suppressor gene, is frequently silenced and inactivated by hypermethylation of its promoter region in several human tumors. However, the association between RASSF1A promoter methylation and gastric cancer risk remains conflicting. The aim of this study was to assess the association of RASSF1A promoter methylation with gastric cancer risk by a comprehensive meta-analysis. Relevant studies were identified by searches of PubMed and Web of Science databases with no restrictions. Combined odds ratio (OR) and 95 % confidence interval (CI) were used to assess the strength of the association between RASSF1A promoter methylation and gastric cancer risk. A chi-square-based Q test and sensitivity analyses were performed to test the between-study heterogeneity and the contributions of single studies to the final results, respectively. Funnel plots were carried out to evaluate publication bias. Overall, a significant association was observed between RASSF1A promoter methylation and gastric cancer risk (OR, 12.67; 95 % CI, 8.12-19.78; p < 0.001) with no between-study heterogeneity. Subgroup analyses further revealed that gastric cancer risk was increased for individuals carrying the methylated RASSF1A compared with those with unmethylated RASSF1A. In addition, no publication bias was detected in the overall and subgroup analyses. This study identified a strong association between RASSF1A promoter methylation and risk of gastric cancer and highlighted a promising potential for RASSF1A promoter methylation in gastric cancer risk prediction.
authors: Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
authors: Dong-Tao
authors: DT
authors: Shi
authors: Mei
authors: M
authors: Han
authors: Nan
authors: N
authors: Gao
authors: Wenyan
authors: W
authors: Tian
authors: Weichang
authors: W
authors: Chen
mesh_terms: D019175:DNA Methylation / Q000235:genetics*; D005006:Ethnicity / Q000235:genetics; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D011379:Prognosis; D011401:Promoter Regions, Genetic; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000473:pathology; D025521:Tumor Suppressor Proteins / Q000235:genetics*
chemical_list: C411762:RASSF1 protein, human; D025521:Tumor Suppressor Proteins
references: Lancet. 1998 Jan 10;351(9096):123-7
references: 9439507
references: Lab Invest. 2003 Apr;83(4):519-26
references: 12695555
references: Dis Markers. 2007;23(1-2):73-87
references: 17325427
references: PLoS One. 2012;7(5):e36780
references: 22615811
references: BMJ. 1997 Sep 13;315(7109):629-34
references: 9310563
references: Cancer Lett. 2011 Dec 1;311(1):85-95
references: 21831520
references: PLoS One. 2012;7(4):e36275
references: 22558417
references: BMC Cancer. 2007 Jul 03;7:120
references: 17608924
references: J Natl Cancer Inst. 1959 Apr;22(4):719-48
references: 13655060
references: Control Clin Trials. 1986 Sep;7(3):177-88
references: 3802833
references: J Clin Epidemiol. 2003 Jan;56(1):1-9
references: 12589864
references: Zhonghua Nei Ke Za Zhi. 2006 Dec;45(12):1008-12
references: 17327001
references: Carcinogenesis. 2011 Mar;32(3):411-6
references: 21156971
references: Epigenomics. 2012 Jun;4(3):279-94
references: 22690664
references: BMC Cancer. 2013 May 25;13:259
references: 23705663
references: Hum Pathol. 2009 Nov;40(11):1534-42
references: 19695681
references: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references: 21296855
references: Epidemiol Rev. 1992;14:154-76
references: 1289110
references: Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S4-11
references: 16341240
references: World J Gastroenterol. 2008 May 21;14(19):3074-80
references: 18494062
references: Int Rev Cytol. 2001;204:49-95
references: 11243597
references: Gastric Cancer. 2002;5(1):6-15
references: 12021854
references: Cancer Res. 2005 May 1;65(9):3497-508
references: 15867337
references: Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3635-40
references: 14506151
references: PLoS One. 2012;7(11):e48300
references: 23139773
references: Cancer Res. 2001 Oct 1;61(19):7034-8
references: 11585730
references: Gastric Cancer. 2002;5 Suppl 1:5-11
references: 12772880
references: Cancer Invest. 2009 May;27(4):459-65
references: 19160099
references: Lab Invest. 2003 May;83(5):635-41
references: 12746473
references: Histol Histopathol. 2002 Jan;17(1):323-9
references: 11813881
references: Histol Histopathol. 2005 Apr;20(2):645-63
references: 15736067
references: Nat Genet. 2000 Jul;25(3):315-9
references: 10888881
references: Int J Cancer. 2002 Dec 20;102(6):623-8
references: 12448005
references: Biol Chem. 2002 Jun;383(6):907-14
references: 12222680
references: J Clin Oncol. 2004 Nov 15;22(22):4632-42
references: 15542813
references: Clin Chim Acta. 2012 Apr 11;413(7-8):787-94
references: 22285775
references: Oncol Rep. 2007 Nov;18(5):1225-30
references: 17914577
references: BMJ. 2003 Sep 6;327(7414):557-60
references: 12958120